相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
Johanna Stachelscheid et al.
CANCERS (2021)
Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC)
Christine Song et al.
BREAST CANCER (2021)
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
Johannes Bloehdorn et al.
NATURE COMMUNICATIONS (2021)
Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling
S. Oberbeck et al.
BLOOD (2020)
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1
Vivien Kohlhaas et al.
BLOOD (2020)
CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy
Lutfi H. Alfarsi et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
The G2-to-M Transition Is Ensured by a Dual Mechanism that Protects Cyclin B from Degradation by Cdc20-Activated APC/C
Pablo Lara-Gonzalez et al.
DEVELOPMENTAL CELL (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
A. Schrader et al.
NATURE COMMUNICATIONS (2018)
CDC20 overexpression leads to poor prognosis in solid tumors A system review and meta-analysis
Shengjie Wang et al.
MEDICINE (2018)
Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
Matthias Schmidt et al.
MOLECULES (2017)
Cryo-EM of Mitotic Checkpoint Complex-Bound APC/C Reveals Reciprocal and Conformational Regulation of Ubiquitin Ligation
Masaya Yamaguchi et al.
MOLECULAR CELL (2016)
The Bub1-Plk1 kinase complex promotes spindle checkpoint signalling through Cdc20 phosphorylation
Luying Jia et al.
NATURE COMMUNICATIONS (2016)
The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL
E. Vasyutina et al.
LEUKEMIA (2015)
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2015)
Mutations driving CLL and their evolution in progression and relapse
Dan A. Landau et al.
NATURE (2015)
NEK9 depletion induces catastrophic mitosis by impairment of mitotic checkpoint control and spindle dynamics
Yasuyuki Kaneta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia
Oleg Fedorchenko et al.
BLOOD (2013)
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia
Georg Hopfinger et al.
CANCER (2013)
Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
Dan A. Landau et al.
CELL (2013)
Molecular characterization of neoplastic and normal sister lymphoblastoid B-cell lines from chronic lymphocytic leukemia
Anna Lanemo Myhrinder et al.
LEUKEMIA & LYMPHOMA (2013)
Tcl 1 interacts with Atm and enhances NF-κB activation in hematologic malignancies
Eugenio Gaudio et al.
BLOOD (2012)
Evolution and Function of the Mitotic Checkpoint
Mathijs Vleugel et al.
DEVELOPMENTAL CELL (2012)
Dephosphorylation of Cdc20 is required for its C-box-dependent activation of the APC/C
Helene Labit et al.
EMBO JOURNAL (2012)
Mad2 and the APC/C compete for the same site on Cdc20 to ensure proper chromosome segregation
Daisuke Izawa et al.
JOURNAL OF CELL BIOLOGY (2012)
Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia
M. Sivina et al.
LEUKEMIA (2012)
Structure of the mitotic checkpoint complex
William C. H. Chao et al.
NATURE (2012)
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Victor Quesada et al.
NATURE GENETICS (2012)
CPORT: A Consensus Interface Predictor and Its Performance in Prediction-Driven Docking with HADDOCK
Sjoerd J. de Vries et al.
PLOS ONE (2011)
Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice
Michael G. Kharas et al.
BLOOD (2010)
The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ-TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling
Mirza Suljagic et al.
BLOOD (2010)
The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
Ulf Klein et al.
CANCER CELL (2010)
Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
Torsten Haferlach et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
M. Hallek et al.
LANCET (2010)
High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia
Marco Herling et al.
BLOOD (2009)
APC/C- and Mad2-mediated degradation of Cdc20 during spindle checkpoint activation
Sheng Ge et al.
CELL CYCLE (2009)
TCL1A expression delineates biological and clinical variability in B-cell lymphoma
Mohit Aggarwal et al.
MODERN PATHOLOGY (2009)
Resistance of mature T cells to oncogene transformation
Sebastian Newrzela et al.
BLOOD (2008)
Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL
Yuri Pekarsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia
Marco Herling et al.
BLOOD (2008)
TCL1 in B-cell tumors retains its normal B-cell pattern of regulation and is a marker of differentiation stage
Marco Herling et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state
M Herling et al.
LEUKEMIA (2006)
IUPred:: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content
Z Dosztányi et al.
BIOINFORMATICS (2005)
Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes
DL Kienle et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
MCM proteins: DNA damage, mutagenesis and repair
JM Bailis et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Structural basis for the co-activation of protein kinase B by T-cell leukemia-1 (TCL1) family proto-oncoproteins
D Auguin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints
A Sancar et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
HADDOCK: A protein-protein docking approach based on biochemical or biophysical information
C Dominguez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
R Bichi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27
T Decker et al.
LEUKEMIA (2002)
Substrate recognition by the Cdc20 and Cdh1 components of the anaphase-promoting complex
CM Pfleger et al.
GENES & DEVELOPMENT (2001)
The protooncogene TCL1 is an Akt kinase coactivator
J Laine et al.
MOLECULAR CELL (2000)
分享论文
